March 27, 2013

IOM Issues Guidelines for Development of 'Omics-based Tests

"The Institute of Medicine today provided a broad set of guidelines for the development of 'omics-based tests, a little more than one year after alleged scientific fraud by a former Duke University researcher was uncovered and shed light on the need for greater oversight."

"The report lays out recommendations for three overarching areas in the development process: discovery, test validation, and evaluation for clinical utility and use."